Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio

The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio

posted on Sep 27, 2007 12:34PM

September 27, 2007 04:30 PM

The TPL Group Files Appeal to Reverse Markman Claim Construction for US 584 Patent in MMP Portfolio

Strategic Appeal Expected to Reverse Single US 584 Instruction Groups Claim Construction in US Court of Appeals for the Federal Circuit

Share
New Message
Please login to post a reply